Assertio Therapeutics Inc (ASRT) has shared an announcement.
Sigurd Kirk, with over two decades of pharmaceutical industry experience, has been appointed to the Board of Directors of a company, effective April 3, 2024. His vast expertise spans branded biopharmaceuticals, medical devices, and generic products, with previous leadership roles at Allergan plc and a history of significant contributions to corporate development and financial strategy. Kirk’s addition to the Board, where he will also serve on the Audit and Compensation Committees, is expected to bring valuable insight into business development and financial planning, enhancing the company’s governance and strategic direction.
For detailed information about ASRT stock, go to TipRanks’ Stock Analysis page.
